Epilepsy remains a significant market with a high demand for innovative therapies. As one of the most prevalent neurological disorders globally, it affects millions of individuals, creating a substantial need for advanced diagnostics and treatments. The market is driven by ongoing research, pharmaceutical investments, and the rising adoption of digital health technologies.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
